Induction of microsomal aryl hydrocarbon (3,4-benzo(alpha)pyrene) hydroxylase and cytochrome P-450K in rat kidney cortex. II. Interactions with the induced hemoprotein

Benzo(α)pyrene treatment resulted in stimulation of only cytochrome P-450_K and benzo(α)pyrene hydroxylase activity in rat kidney cortex microsomes. Spectral properties of cytochrome P-450_K showed that the 452 nm peak of the reduced hemoprotein CO-complex was not shifted in benzo(α)pyrene-treated rats. The off-balance absolute spectrum of oxidized cytochrome P-450_K displayed an absorption maximum at 414 nm, another band at 385 nm, and a distinct shoulder at 398 nm. Addition of benzo(α)pyrene to kidney microsomes resulted in a type I spectral change seen only in benzo(α)pyrene-treated rats. The addition of ethyl isocyanide to dithionitetreated microsomes from control rats gave rise to two Soret peaks, 432 nm and 458 nm. These peaks were proportionately increased in benzo(α)pyrene-treated rats; furthermore, the 458 nm peak was not shifted. The relative heights of the two peaks were in a pH-dependent equilibrium similar to that observed in liver; however, in contrast to liver, the pH, at which the ratio of the peak heights equals one, was the same for both benzo(α)pyrene-treated and control microsomes. These data indicate that the newly induced hemoprotein has spectral properties markedly different from those of the benzo(α)pyrene-induced liver hemoprotein, yet similar to those of the “noninduced” kidney hemoprotein. α-Naphthoflavone, an inhibitor of the aryl hydroxylase system, induced a type I spectral change, suggesting the mode of action of α-naphthoflavone to be its interaction with cytochrome P-450_K probably at or near the active site. Finally, the rate of reduction of cytochrome P-450_K was not affected by the presence of benzo(α)pyrene.